These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 25243616)
41. Progress and prospects for targeting Hsp90 to treat fungal infections. Veri A; Cowen LE Parasitology; 2014 Aug; 141(9):1127-37. PubMed ID: 24560124 [TBL] [Abstract][Full Text] [Related]
42. The fungal Achilles' heel: targeting Hsp90 to cripple fungal pathogens. Cowen LE Curr Opin Microbiol; 2013 Aug; 16(4):377-84. PubMed ID: 23588026 [TBL] [Abstract][Full Text] [Related]
43. Phosphoproteomics of Aspergillus fumigatus Exposed to the Antifungal Drug Caspofungin. Mattos EC; Palmisano G; Goldman GH mSphere; 2020 May; 5(3):. PubMed ID: 32461274 [No Abstract] [Full Text] [Related]
44. A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi. Dos Reis TF; de Castro PA; Bastos RW; Pinzan CF; Souza PFN; Ackloo S; Hossain MA; Drewry DH; Alkhazraji S; Ibrahim AS; Jo H; Lightfoot JD; Adams EM; Fuller KK; deGrado WF; Goldman GH Nat Commun; 2023 Apr; 14(1):2052. PubMed ID: 37045836 [TBL] [Abstract][Full Text] [Related]
45. Brilacidin, a host defense peptide mimetic, potentiates ibrexafungerp antifungal activity against the human pathogenic fungus Dos Reis TF; Diehl C; Pinzan CF; de Castro PA; Goldman GH Microbiol Spectr; 2024 Aug; 12(8):e0088824. PubMed ID: 38980033 [TBL] [Abstract][Full Text] [Related]
46. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. Steinbach WJ; Singh N; Miller JL; Benjamin DK; Schell WA; Heitman J; Perfect JR Antimicrob Agents Chemother; 2004 Dec; 48(12):4922-5. PubMed ID: 15561883 [TBL] [Abstract][Full Text] [Related]
51. Azole resistant Aspergillus fumigatus: an emerging problem. Lelièvre L; Groh M; Angebault C; Maherault AC; Didier E; Bougnoux ME Med Mal Infect; 2013 Apr; 43(4):139-45. PubMed ID: 23562488 [TBL] [Abstract][Full Text] [Related]
52. MOB-mediated regulation of septation initiation network (SIN) signaling is required for echinocandin-induced hyperseptation in Thorn HI; Guruceaga X; Martin-Vicente A; Nywening AV; Xie J; Ge W; Fortwendel JR mSphere; 2024 Mar; 9(3):e0069523. PubMed ID: 38349166 [No Abstract] [Full Text] [Related]
53. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy. Amorim A; Guedes-Vaz L; Araujo R Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740 [TBL] [Abstract][Full Text] [Related]
54. Aspergillus species intrinsically resistant to antifungal agents. Van Der Linden JW; Warris A; Verweij PE Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634 [TBL] [Abstract][Full Text] [Related]
55. Elucidating drug resistance in human fungal pathogens. Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351 [TBL] [Abstract][Full Text] [Related]
56. Membrane and cell wall targets in Aspergillus fumigatus. Beauvais A; Latgé JP Drug Resist Updat; 2001 Feb; 4(1):38-49. PubMed ID: 11512152 [TBL] [Abstract][Full Text] [Related]
58. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. Lewis RE; Liao G; Hou J; Prince RA; Kontoyiannis DP J Antimicrob Chemother; 2011 Jun; 66(6):1324-31. PubMed ID: 21486855 [TBL] [Abstract][Full Text] [Related]
59. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms. Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968 [TBL] [Abstract][Full Text] [Related]
60. Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression. Morelli KA; Kerkaert JD; Cramer RA PLoS Pathog; 2021 Aug; 17(8):e1009794. PubMed ID: 34437655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]